SCHEMBL7937503

SCHEMBL7937503

CSc1ccc(/C=C2\C(C)=C(OC(C)=O)c3cc(F)ccc32)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 11/20 0.64
CYP1A2 P05177 3/20 0.64
MAPT P10636 3/20 0.64
MAPK1 P28482 3/20 0.64
PTGS1 P23219 2/20 0.64
PTGS2 P35354 2/20 0.64
TDP1 Q9NUW8 2/20 0.64
EGFR P00533 1/20 0.64
ADORA3 P0DMS8 1/20 0.64
DRD1 P21728 1/20 0.64
OPRM1 P35372 1/20 0.64
PSEN1 P49768 1/20 0.64
PSEN2 P49810 1/20 0.64
APH1B Q8WW43 1/20 0.64
NCSTN Q92542 1/20 0.64
APH1A Q96BI3 1/20 0.64
PSENEN Q9NZ42 1/20 0.64
CYSLTR1 Q9Y271 1/20 0.64
PTGDR2 Q9Y5Y4 1/20 0.64
RXRA P19793 5/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5712308 1.00 PPARG (0.64) PPARGCYP1A2MAPTMAPK1PTGS1
SCHEMBL7929605 0.89 PPARG (0.65) PPARGCYP1A2MAPTMAPK1PTGS1
SCHEMBL7632829 0.87 PPARG (0.48) PPARGCYP1A2MAPTMAPK1PTGS1
SCHEMBL7942618 0.86 PPARG (0.47) PPARGCYP1A2MAPTMAPK1PTGS1
SCHEMBL7929607 0.86 PPARG (0.67) PPARGCYP1A2MAPTMAPK1PTGS1
SCHEMBL7929608 0.86 PPARG (0.67) PPARGCYP1A2MAPTMAPK1PTGS1
SCHEMBL7632053 0.85 CYP1A2 (0.47) PPARGCYP1A2MAPTMAPK1PTGS1
SCHEMBL7638531 0.84 PPARG (0.48) PPARGCYP1A2MAPTMAPK1PTGS1
SCHEMBL7635986 0.84 PPARG (0.48) PPARGCYP1A2MAPTMAPK1PTGS1
SCHEMBL8154644 0.84 MAPT (0.46) PPARGCYP1A2MAPTMAPK1PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6232312-B1 ADMINISTERING A COMBINATION OF INDENE AND PYRIMIDO(5,4-D)PYRIMIDINE DERIVATIVES TO TREAT PREPANCREATIC CANCER CELL PATHWAYS, INC. 2001-05-15 US disclosed